Breaking News Bar

Business News and Information

As Aratana awaits $245M sale closing, it wins fifth FDA approval in three years

Aratana Therapeutics, which announced its plan to sell to Elanco Animal Health Inc. for $245 million in late April, has won FDA approval for a smaller vial of the pet therapeutics company's drug Nocita.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear